Early treatment with rasburicase and risk of kidney replacement therapy and death in adults with tumour lysis syndrome: emulated target trial
Tushar Shenoy, Daniel Sanchez-Almanzar, Julie‐Alexia Dias, Robert Hayden et autres
2 citationsBMJ
Ann S. LaCasce
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
394Publications signalées
19459Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchCNS Lymphoma Diagnosis and TreatmentViral-associated cancers and disordersCAR-T cell therapy research
Publications récentes
MRD-negativity by PBMCs and ctDNA confirms deep and durable responses following epcoritamab monotherapy in R/R FL
Işıl Altıntaş, Christopher Morehouse, Elena Favaro, Ali Rana et autres
0 citationsBlood Advances
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin
Shin Yeu Ong, Lu Chen, Jomel Meeko Manzano, Reid W. Merryman et autres
0 citationsBlood Cancer Journal
Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials
0 citationsJournal of Clinical Oncology
Enhancing Radiation Therapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process in AHOD2131
Andrea Lo, Sarah A. Milgrom, Raymond Mailhot Vega, David Hodgson et autres
1 citationInternational Journal of Radiation Oncology*Biology*Physics
Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop
Reid W. Merryman, Sarah C. Rutherford, Stephen M. Ansell, Philippe Armand et autres
4 citationsBlood Advances
Enhancing Radiotherapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process in AHOD2131
Andrea Lo, Sarah A. Milgrom, Raymond B. Mailhot Vega, Darren Hodgson et autres
0 citationsKlinische Pädiatrie
AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy to Immuno-oncology for Children & Adults with Newly Diagnosed Stage I and II Hodgkin Lymphoma
Jennifer Seelisch, Boyu Hu, Lindsay A. Renfro, Frank G. Keller et autres
0 citationsKlinische Pädiatrie
Outcomes and prognostic factors in patients with follicular lymphoma treated with front-line bendamustine and rituximab
Hari S. Raman, Robert Redd, Inhye E. Ahn, Amy Bessnow et autres
0 citationsBlood
Phase I/II study of acalabrutinib, venetoclax, and obinutuzumab in patients with relapsed/refractory and previously untreated Mantle Cell Lymphoma (MAVO)
Austin Kim, Peter A. Riedell, Christine E. Ryan, Robert Redd et autres
8 citationsBlood
Glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with high-tumor burden follicular lymphoma: First results of a multicenter phase II trial
Reid W. Merryman, Gottfried von Keudell, Robert Redd, Heather Walker et autres
0 citationsBlood
Rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma: Results of a multicenter phase II trial
Reid W. Merryman, Danielle Wallace, Robert Redd, Heather Walker et autres
0 citationsBlood
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.